Catalogo dei prodotti della ricerca

VERRIENTI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.051
AS - Asia 2.827
EU - Europa 1.855
SA - Sud America 381
AF - Africa 181
OC - Oceania 13
Totale 10.308
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.956
SG - Singapore 996
IT - Italia 851
HK - Hong Kong 482
CN - Cina 475
VN - Vietnam 356
BR - Brasile 281
IN - India 230
DE - Germania 198
SE - Svezia 198
FI - Finlandia 150
FR - Francia 96
MA - Marocco 95
RU - Federazione Russa 78
BD - Bangladesh 59
GB - Regno Unito 51
CA - Canada 50
JP - Giappone 45
UA - Ucraina 41
AR - Argentina 39
BG - Bulgaria 34
ZA - Sudafrica 34
ID - Indonesia 32
NL - Olanda 32
BE - Belgio 31
MX - Messico 30
IQ - Iraq 27
PH - Filippine 23
KR - Corea 21
AT - Austria 18
EC - Ecuador 14
AU - Australia 13
IE - Irlanda 13
TR - Turchia 13
VE - Venezuela 12
KE - Kenya 11
PK - Pakistan 11
TG - Togo 11
ES - Italia 9
RO - Romania 9
CO - Colombia 8
EG - Egitto 8
LT - Lituania 8
PL - Polonia 8
CI - Costa d'Avorio 7
CL - Cile 7
CH - Svizzera 6
MY - Malesia 6
NP - Nepal 6
PY - Paraguay 6
UZ - Uzbekistan 6
BO - Bolivia 5
CR - Costa Rica 5
DK - Danimarca 5
PE - Perù 5
CZ - Repubblica Ceca 4
DZ - Algeria 4
JO - Giordania 4
SA - Arabia Saudita 4
TH - Thailandia 4
TW - Taiwan 4
UY - Uruguay 4
GR - Grecia 3
HU - Ungheria 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
SN - Senegal 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
ET - Etiopia 2
GE - Georgia 2
HR - Croazia 2
KG - Kirghizistan 2
PA - Panama 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BZ - Belize 1
CG - Congo 1
EE - Estonia 1
GI - Gibilterra 1
JM - Giamaica 1
KW - Kuwait 1
LV - Lettonia 1
MT - Malta 1
MZ - Mozambico 1
NI - Nicaragua 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SC - Seychelles 1
SV - El Salvador 1
Totale 10.308
Salva come PNG Salva come JPEG
Città #
Fairfield 539
Singapore 513
Ashburn 478
Hong Kong 452
San Jose 331
Rome 328
Dallas 306
Chandler 233
Woodbridge 220
Houston 210
Seattle 204
Cambridge 173
Wilmington 173
Ann Arbor 149
Los Angeles 127
Ho Chi Minh City 123
Beijing 111
Dearborn 105
Casablanca 88
Santa Clara 86
San Paolo di Civitate 81
Hanoi 80
Helsinki 80
Princeton 70
Munich 63
Buffalo 62
Frankfurt am Main 55
Lauterbourg 55
Lawrence 55
New York 55
San Diego 49
Plano 48
Fremont 43
Boston 39
Milan 37
The Dalles 37
Council Bluffs 34
Boardman 33
Chicago 33
Cosenza 33
Sofia 33
Millbury 31
Johannesburg 28
Tokyo 28
Hillsboro 26
Brussels 23
Jakarta 22
São Paulo 22
Andover 21
Toronto 21
Turku 21
Orem 20
Phoenix 20
Hefei 17
Redondo Beach 17
Bengaluru 16
Falkenstein 16
Moscow 16
Naples 16
Da Nang 14
London 13
Nuremberg 13
Bologna 12
Dublin 12
Falls Church 12
Federal 12
Elk Grove Village 11
Lomé 11
Ottawa 11
Lappeenranta 10
Montreal 10
Paris 10
Porto Alegre 10
Salt Lake City 10
Baghdad 9
Guangzhou 9
Belo Horizonte 8
Cagliari 8
Chennai 8
Kunming 8
Nairobi 8
Norwalk 8
Stockholm 8
Vienna 8
Waanrode 8
Abidjan 7
Brooklyn 7
Carraia Nord 7
Denver 7
Jacksonville 7
Kyiv 7
Legnano 7
Mexico City 7
Pune 7
Seoul 7
Shanghai 7
Sterling 7
Tivoli 7
Amsterdam 6
Atlanta 6
Totale 6.769
Salva come PNG Salva come JPEG
Nome #
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance 359
Connectivity significance for disease gene prioritization in an expanding universe 256
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 216
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue 203
Risk stratification of neck lesions detected sonographically during the follow-up of differentiated thyroid cancer 201
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: a case report 198
In silico drug repurposing in COVID-19. A network-based analysis 190
A novel de novo germ-line V292M mutation in the extracellular region of RET in a patient with phaeochromocytoma and medullary thyroid carcinoma: functional characterization 186
Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up 185
BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response 184
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 184
BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study 180
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 180
A new germline VHL gene mutation in three patients with apparently sporadic pheochromocytoma 177
Loss of function SETD2 mutations in poorly differentiated metastases from two Hürthle cell carcinomas of the thyroid 158
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 157
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency 157
A novel splicing mutation in the ABCA1 gene, causing Tangier disease and familial HDL deficiency in a large family 156
Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression 155
Expression of YAP1 in aggressive thyroid cancer 155
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers 152
Thyroid cancer patients with no evidence of disease: the need for repeat neck ultrasound 151
BRAF(V600E) mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas 150
A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma 150
MicroRNA-based molecular classification of papillary thyroid carcinoma 148
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 146
Coexistence of multiple endocrine neoplasia type 1 and type 2 in a large Italian family 145
Coincidence of Neurofibromatosis Type 1 and Multiple Endocrine Neoplasia Type 2 144
The role of FOSL1 in stem-like cell reprogramming processes 144
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules 140
BRAF mutations in papillary thyroid carcinomas inhibit genes involved in iodine metabolism 139
Thyroid hormone therapy in differentiated thyroid cancer 139
Circulating cell-free DNA (cfDNA) in patients with medullary thyroid carcinoma is characterized by specific fragmentation and methylation changes with diagnostic value 138
A novel double mutation val648ile and val804leu or ret proto-oncogene in multiple endocrine neoplasia type 2 136
Genetic determinants and early carotid atherosclerosis: is there a role for the ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP-1) K121Q polymorphism? Preliminary results in non diabetic individuals 136
Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells 135
RET mutation and increased angiogenesis in medullary thyroid carcinomas 135
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 133
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 133
The ectonucleotide pyrophosphatase phosphodiesterase 1 (ENPP1) K121Q polymorphism modulates the beneficial effect of weight loss on fasting glucose in non-diabetic individuals 131
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 129
Growth Factor Receptors Gene Expression and Akt Phosphorylation in Benign Human Thyroid Nodules are Unaffected by Chronic Thyrotropin Suppression 127
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer 126
Regulation of sodium/iodide symporter and lactoperoxidase expression in four human breast cancer cell lines 124
Serologic and genetic markers of celiac disease: A sequential study in the screening of first degree relatives 120
Multiple catecholamine-secreting paragangliomas: Diagnosis after hemorrhagic stroke in a young woman 119
The Interplay between Liver and Adipose Tissue in the Onset of Liver Diseases: Exploring the Role of Vitamin Deficiency 116
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumours 116
Sunitinib Exerts Only Limited Effects on the Proliferation and Differentiation of Anaplastic Thyroid Cancer Cells 115
Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach 112
In vivo and in vitro characterization of a novel germline RET mutation associated with low-penetrant nonaggressive familial medullary thyroid carcinoma 111
Targeting post-translational histone modifications for the treatment of non-medullary thyroid cancer 109
Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside 109
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma 108
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer 107
Expression and localization of the sodium/iodide symporter (NIS) in testicular cells 107
Late recurrence after surgical resection of a pancreatic tumor in von Hippel-Lindau disease 105
Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma 105
GAD and IA-2 autoantibody detection in type 1 diabetic patient saliva 99
Comment on: BRAF mutation analysis by ARMS-PCR refines thyroid nodule management 99
SEaCorAl: Identifying and contrasting the regulation-correlation bias in RNA-Seq paired expression data of patient groups 98
Tissue transglutaminase autoantibody detection in human saliva: a powerful method for celiac disease screening 96
The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment 93
The role of miR-139-5p in radioiodine-resistant thyroid cancer 93
GAD and IA-2 immunoreactivity in type 1 diabetic patient saliva 90
Celiac disease-associated transglutaminase autoantibody target domain at diagnosis are age and sex dependent. 89
Low-risk papillary thyroid microcarcinoma: Optimal management toward a more conservative approach 89
XL184 (cabozantinib) for medullary thyroid carcinoma 89
Establishment and maintenance of thyroid organoids from human cancer cells 89
The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations 87
Thyrotoxic periodic paralysis in an Italian man: clinical manifestation and genetic analysis 81
IA-2 combined epitope assay: a new, highly sensitive approach to evaluate IA-2 humoral autoimmunity in type 1 diabetes 80
The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age 74
Type 2 deiodinase polymorphism (THR92ALA) predicts L-thyroxine dose to achieve target TSH levels in thyroidectomized patients. 74
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 74
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility 71
null 67
Evidence of a selective epitope loss of anti-transglutaminase immureactivity in gluten-free diet celiac sera: a new tool to distinguish disease-specific immureactivities. 67
Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance 65
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 62
Excellent RAI therapeutic response on a patient presenting skull metastasis of follicular thyroid cancer after 15 years 47
Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation 42
Precision oncology for RET-related tumors 40
Totale 10.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 0 35 65
2021/2022983 21 66 94 40 114 43 19 88 75 56 216 151
2022/2023905 158 221 67 73 81 86 29 56 64 4 24 42
2023/2024464 25 75 10 38 45 85 21 30 4 47 49 35
2024/20251.621 30 29 81 117 89 106 89 76 275 180 124 425
2025/20264.343 417 434 323 427 503 247 673 176 322 484 337 0
Totale 10.682